Skip to main content
NIH funding notice RFA-MH-21-240

Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required)

Closed on November 9, 2021.

Posted
June 25, 2021
Close date
November 9, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,091,629 in first-year total cost, median $1,045,815.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-N (04)]2

Most frequent institutions

  1. MICHIGAN STATE UNIVERSITY1
  2. UNIVERSITY OF DENVER (COLORADO SEMINARY)1
Competing awards under RFA-MH-21-240 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022The ROSE Scale-Up Study: Informing a decision about ROSE as universal postpartum depression prevention1R01MH130948-01JOHNSON, JENNIFER EZLOTNICK, CARONMICHIGAN STATE UNIVERSITY, MI$1,333,743ZMH1
2022Group-based Prevention of Postpartum Depression: In-person vs. Virtual Delivery1R01MH130976-01DAVIS, ELYSIA POGGIRHOADES, GALENAUNIVERSITY OF DENVER (COLORADO SEMINARY), CO$757,886ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.